获取演示
Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Fractyl Health

六月 2026

六月 2026的Fractyl Health市场份额分析

Please sign up for ongoing news and information 3 Van de Graaff DriveSuite 200Burlington, MA 01803 For General Inquiries: (781) 902-8800info@fractyl.com For Investor Inquiries: Lara Smith WeberChief Financial Officer(617) 835-5912 Brian LuqueHead of Investor Relations and Corporate Development(951) 206-1200 IR@fractyl.com
成立年份2010
员工51 - 200
年营收$5M - $10M
fractyl.com
Fractyl Health
Fractyl Health(包含公司地区分支机构)
  • fractyl.com
    fractyl.com
查看更多网站流量和参与度信息

Fractyl Health收入截至 六月 2026为 5M - 10M

Fractyl Health主要域名产生的收入

3 年中Fractyl Health主要域名的收入

Fractyl Health主要域名的收入


Fractyl Health热门域名的总访问量

了解Fractyl Health市场份额和潜在市场覆盖范围。

过去 3 个月的总访问量

子公司明细

Fractyl Health热门域名的平均访问时长

分析Fractyl Health参与度指标。

过去 3 个月的平均访问时长

子公司明细

Fractyl Health热门域名的平均页面浏览量

了解Fractyl Health如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。

过去 3 个月的平均页面浏览量

子公司明细

想要获取更深入的流量洞见?

过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。



Fractyl Health 采用的主要技术

这些是排名前 Fractyl Health 的顶级域名所使用的网站技术(按行业分列)

付款和货币 (10)

Cart Functionality

Cart Functionality

小部件 (7)

电子商务 (6)

WooCommerce

WooCommerce

付费广告 (4)

DoubleClick

DoubleClick

更多技术

13

查看全部

准备好发现优质潜在客户了吗?

借助 Similarweb 销售情报解决方案,确定任意网站使用了哪些技术来设计完美的销售宣传,并缩短销售周期。


Fractyl Health 的新闻与信号

借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。

新闻Fractyl Laboratories, Inc. hired Mike Zumdahl as senior vice president of market access and commercial strategy on Jun 1st '26.Fractyl Health has hired medtech reimbursement and market access executive Mike Zumdahl as senior vice president of market access and commercial strategy, a move that shifts the company's focus beyond clinical development and toward the commercialization infrastructure needed to support its lead obesity therapy candidate, Revita.
新闻Fractyl Laboratories, Inc. launched candidate drug RJVA-001 on Rejuvea Smart GLP-1 gene therapy platform on May 11th '26.On May 11, 2026, Fractyl Health announced that it has obtained approval for a clinical trial application in the Netherlands and will launch the first candidate drug RJVA-001 on its Rejuvea Smart GLP-1 gene therapy platform! /The first human clinical trial.
新闻Fractyl Laboratories, Inc. attended event BofA Securities 2026 Health Care Conference on May 14th '26.The Company also announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of Fractyl Health, will present at the BofA Securities 2026 Health Care Conference on Thursday, May 14, 2026, at 9:20 a.m. PT (12:20 p.m. ET).

查看 Fractyl Health 的所有信号

让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。